Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2025-12-26 @ 3:45 PM
Study NCT ID:
NCT06065059
Status:
TERMINATED
Last Update Posted:
2024-08-13
First Post:
2023-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors
Sponsor:
Tango Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-22
Completion Date Type:
ACTUAL
First Submit Date:
2023-09-15
First Submit QC Date:
None
Study First Post Date:
2023-10-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-12
Last Update Post Date:
2024-08-13
Last Update Post Date Type:
ACTUAL